These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Activated microglia do not increase 18 kDa translocator protein (TSPO) expression in the multiple sclerosis brain. Nutma E, Gebro E, Marzin MC, van der Valk P, Matthews PM, Owen DR, Amor S. Glia; 2021 Oct; 69(10):2447-2458. PubMed ID: 34145928 [Abstract] [Full Text] [Related]
12. Regulation of microglial TMEM119 and P2RY12 immunoreactivity in multiple sclerosis white and grey matter lesions is dependent on their inflammatory environment. van Wageningen TA, Vlaar E, Kooij G, Jongenelen CAM, Geurts JJG, van Dam AM. Acta Neuropathol Commun; 2019 Dec 11; 7(1):206. PubMed ID: 31829283 [Abstract] [Full Text] [Related]
16. Axonal injury in the cerebral normal-appearing white matter of patients with multiple sclerosis is related to concurrent demyelination in lesions but not to concurrent demyelination in normal-appearing white matter. Narayanan S, Francis SJ, Sled JG, Santos AC, Antel S, Levesque I, Brass S, Lapierre Y, Sappey-Marinier D, Pike GB, Arnold DL. Neuroimage; 2006 Jan 15; 29(2):637-42. PubMed ID: 16126413 [Abstract] [Full Text] [Related]
17. Downregulation of macrophage inhibitory molecules in multiple sclerosis lesions. Koning N, Bö L, Hoek RM, Huitinga I. Ann Neurol; 2007 Nov 15; 62(5):504-14. PubMed ID: 17879969 [Abstract] [Full Text] [Related]
20. Molecular signature of different lesion types in the brain white matter of patients with progressive multiple sclerosis. Elkjaer ML, Frisch T, Reynolds R, Kacprowski T, Burton M, Kruse TA, Thomassen M, Baumbach J, Illes Z. Acta Neuropathol Commun; 2019 Dec 11; 7(1):205. PubMed ID: 31829262 [Abstract] [Full Text] [Related] Page: [Next] [New Search]